Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies ...
Jul 6, 2021
0
138
The human heart works under high demand, constantly pumping oxygen-rich blood through the body. When faced with disease, however, fulfilling this demand can become increasingly difficult and harmful. In the case of chronic ...
Mar 30, 2021
0
49
Nearly a half-million people a year die from sudden cardiac death (SCD) in the U.S.—the result of malfunctions in the heart's electrical system.
Feb 17, 2021
0
80
Inflammation is part of an immune response to fight off pathogens and clear infections. But patients with cardiac disease often have chronic inflammation that damages their hearts, even with no infection present.
Feb 3, 2021
0
41
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
Jan 25, 2021
0
39
UC San Francisco scientists have discovered a new way to control the immune system's 'natural killer' (NK) cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The ...
Jan 8, 2021
0
82
A protein known mostly for its role in the brain may be a key player in the cardiovascular system as well, according to a Northwestern Medicine study published in Nature.
Dec 10, 2020
0
58
Extracellular vesicles (EVs)—nanometer sized messengers that travel between cells to deliver cues and cargo—are promising tools for the next generation of therapies for everything from autoimmune and neurodegenerative ...
Oct 15, 2020
0
51
Science has long known that recovery from experimental heart attacks is improved by injection of a mixture of heart muscle cells, endothelial cells and smooth muscle cells, yet results have been limited by poor engraftment ...
Sep 29, 2020
0
66
A team including Wei Liu, assistant professor in ASU's School of Molecular Sciences (SMS) and the Biodesign Institute's Center for Applied Structural Discovery, has published a paper today in Molecular Cell that offers promising ...
Aug 19, 2020
0
100
